Hiroyuki Katayama Selected Research

Hiroyuki Katayama Research Topics

Disease

29	Neoplasms (Cancer) 05/2022 - 06/2008
5	Adenocarcinoma 01/2022 - 11/2017
5	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2019
5	Breast Neoplasms (Breast Cancer) 05/2021 - 08/2015
4	Adenocarcinoma of Lung 05/2022 - 12/2014
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 06/2008
4	Lung Neoplasms (Lung Cancer) 01/2018 - 12/2016
3	Carcinogenesis 05/2021 - 12/2020
3	Triple Negative Breast Neoplasms 01/2020 - 08/2015
3	Cysts 09/2012 - 08/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2021 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2020
2	Infections 01/2016 - 11/2010
2	Inflammation (Inflammations) 12/2009 - 04/2009
1	Rectal Neoplasms (Rectal Cancer) 07/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Colonic Neoplasms (Colon Cancer) 12/2020
1	Polyps 12/2020
1	Chromosomal Instability (Chromosome Stability) 12/2020
1	Microsatellite Instability 12/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Ovarian Neoplasms (Ovarian Cancer) 02/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Bronchiolitis Obliterans Syndrome 01/2020

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2008
8	AntigensIBA 05/2021 - 08/2015
7	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2016
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
5	ProteomeIBA 05/2020 - 06/2008
4	AutoantibodiesIBA 05/2021 - 08/2015
4	Neoplasm Antigens (Tumor Antigens)IBA 05/2021 - 01/2019
4	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2019
4	Peptides (Polypeptides)IBA 01/2021 - 01/2017
3	Biological ProductsIBA 01/2022 - 06/2008
3	Small Interfering RNA (siRNA)IBA 10/2020 - 12/2014
3	Drinking WaterIBA 01/2016 - 01/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 11/2020
2	Blood Proteins (Serum Proteins)IBA 07/2021 - 01/2019
2	Long Noncoding RNAIBA 12/2020 - 10/2020
2	Conditioned Culture MediaIBA 05/2020 - 12/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 01/2020
2	Estrogen ReceptorsIBA 01/2020 - 08/2015
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
2	Complement System Proteins (Complement)IBA 01/2019 - 11/2017
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2017 - 01/2017
2	WastewaterIBA 05/2016 - 06/2012
2	RNA (Ribonucleic Acid)IBA 11/2010 - 06/2008
1	EnzymesIBA 05/2022
1	kynureninaseIBA 05/2022
1	KynurenineIBA 05/2022
1	Tryptophan (L-Tryptophan)FDA Link 05/2022
1	HydrolasesIBA 01/2022
1	Carboxylesterase (Hydrolase S)IBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	ProdrugsIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Thyroid Nuclear Factor 1IBA 01/2022
1	Epoxide HydrolasesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 10/2021
1	Proline (L-Proline)FDA Link 10/2021
1	Alanine (L-Alanine)FDA Link 10/2021
1	Cathepsin BIBA 07/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2021
1	Insulin-Like Growth Factor Binding Protein 4IBA 07/2021
1	Immunoglobulin G (IgG)IBA 05/2021
1	EpitopesIBA 05/2021
1	Protein-Arginine Deiminase Type 2IBA 01/2021
1	Protein-Arginine DeiminasesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	CitrullineIBA 01/2021
1	AzoxymethaneIBA 12/2020
1	Aurora Kinase BIBA 12/2020
1	Dextran SulfateIBA 12/2020
1	folfirinoxIBA 11/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020
1	Leucovorin (Folinic Acid)FDA Link 11/2020
1	Fluorouracil (Carac)FDA LinkGeneric 11/2020
1	Recombinant ProteinsIBA 02/2020
1	UbiquitinIBA 01/2020
1	N',N''-diacetylspermineIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	SpermineIBA 01/2020
1	Spermine SynthaseIBA 01/2020
1	Proteasome InhibitorsIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	PolyaminesIBA 01/2020
1	amsonic acid (DAS)IBA 01/2020
1	Retinoblastoma ProteinIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020

Therapy/Procedure

4	Therapeutics 12/2020 - 01/2016
2	Drug Therapy (Chemotherapy) 03/2020 - 01/2017
2	Immunotherapy 01/2017 - 01/2017
1	Neoadjuvant Therapy 07/2021
1	Combination Drug Therapy (Combination Chemotherapy) 11/2020
1	Precision Medicine 03/2020